Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 9

1.

IPH2101, a novel anti-inhibitory KIR antibody, and lenalidomide combine to enhance the natural killer cell versus multiple myeloma effect.

Benson DM Jr, Bakan CE, Zhang S, Collins SM, Liang J, Srivastava S, Hofmeister CC, Efebera Y, Andre P, Romagne F, Bléry M, Bonnafous C, Zhang J, Clever D, Caligiuri MA, Farag SS.

Blood. 2011 Dec 8;118(24):6387-91. doi: 10.1182/blood-2011-06-360255. Epub 2011 Oct 26.

2.

The role of natural killer cells in immunity against multiple myeloma.

Godfrey J, Benson DM Jr.

Leuk Lymphoma. 2012 Sep;53(9):1666-76. doi: 10.3109/10428194.2012.676175. Epub 2012 Apr 19. Review.

PMID:
22423650
3.

Lenalidomide mode of action: linking bench and clinical findings.

Davies F, Baz R.

Blood Rev. 2010 Nov;24 Suppl 1:S13-9. doi: 10.1016/S0268-960X(10)70004-7. Review.

PMID:
21126632
4.

Mechanisms of Action of Lenalidomide in B-Cell Non-Hodgkin Lymphoma.

Gribben JG, Fowler N, Morschhauser F.

J Clin Oncol. 2015 Sep 1;33(25):2803-11. doi: 10.1200/JCO.2014.59.5363. Epub 2015 Jul 20. Review.

5.

Daratumumab: monoclonal antibody therapy to treat multiple myeloma.

Xia C, Ribeiro M, Scott S, Lonial S.

Drugs Today (Barc). 2016 Oct;52(10):551-560. Review.

PMID:
27910963
6.

Activation of NK cells and disruption of PD-L1/PD-1 axis: two different ways for lenalidomide to block myeloma progression.

Giuliani M, Janji B, Berchem G.

Oncotarget. 2017 Apr 4;8(14):24031-24044. doi: 10.18632/oncotarget.15234. Review.

7.

Treatment of multiple myeloma with the immunostimulatory SLAMF7 antibody elotuzumab.

Einsele H, Schreder M.

Ther Adv Hematol. 2016 Oct;7(5):288-301. Epub 2016 Jul 15. Review.

8.

A vision of KIR variation at super resolution.

Hammond JA, Carrington M, Khakoo SI.

Immunology. 2016 Jul;148(3):249-52. doi: 10.1111/imm.12606. Epub 2016 Apr 5. Review.

PMID:
26938992
9.

Monitoring NK cell activity in patients with hematological malignancies.

Viel S, Charrier E, Marçais A, Rouzaire P, Bienvenu J, Karlin L, Salles G, Walzer T.

Oncoimmunology. 2013 Sep 1;2(9):e26011. Epub 2013 Sep 12. Review.

Supplemental Content

Support Center